A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

Weight-loss injections slash alcohol cravings and can curb heavy drinking, new research suggests.The first clinical trial of its kind found the weekly jab semaglutide, also known as Ozempic and Wegovy,

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern California looked at a positive side

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol cravings and consumption.

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, published Wednesday by JAMA Psychiatry, looked into 48 people the

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.